Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats

Journal of Pharmacy and Pharmacology

Volumn 53, Issue 6, 2001, Pages 823-829

  Torii, M ^a   Takiguchi, Y ^a   Saito, F ^a   Izumi, M ^a   Yokota, M ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CILASTATIN PLUS IMIPENEM; IMIPENEM; PANIPENEM; PANIPENEM PLUS BETAMIPRON; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENSITY GRADIENT; DRUG ACCUMULATION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG METABOLISM; DRUG TRANSPORT; EPILEPSY; INTESTINE ABSORPTION; INTESTINE PERFUSION; MALE; NONHUMAN; RAT; SEROSA;

ADMINISTRATION, ORAL; ANIMALS; ANTICONVULSANTS; BIOLOGICAL TRANSPORT, ACTIVE; DRUG INTERACTIONS; IMIPENEM; INFUSIONS, INTRAVENOUS; INTESTINAL ABSORPTION; MALE; RATS; RATS, SPRAGUE-DAWLEY; THIENAMYCINS; VALPROIC ACID;

EID: 0034988068     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357011776171     Document Type: Article

References (23)

1. Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine
2. Carbapenems, a new class of beta-lactam antibiotics: Discovery and development of imipenem/cilastatin
3. Effects of carbamazepine on valproic acid kinetics in normal subjects
4. Age-dependent intestinal absorption of valproic acid in the rat
5. Valproate: Monotherapy and polytherapy
6. Lowering of plasma during concomitant therapy with meropenem and amikacin
7. Disposition of valproic acid in the rat: Dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect
8. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers
9. Physiological disposition of imipenem and cilastatin sodium in rats
10. Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats
11. Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron
12. An update on sodium valproate
13. Reduction of steady state valproate levels by other antiepileptic drugs
14. Kinetics of zinc absorption by luminally and vascularly perfused rat intestine
15. Metabolic studies on panipenem/betamipron distribution, metabolism and excretion of panipenem/betamipron in rats and dogs
16. cDNA cloning and functional characterization of rat intestinal monocarboxylate transporter
17. Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids
18. Intestinal brush-border membrane transport of monocarboxylic acids mediated by proton-coupled transport and anion antiport mechanisms
19. Tissue concentrations and clinical efficacy of panipenem/betamipron in surgical infections
20. Gas chromatographic measurement of plasma levels of sodium valproate: Tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics
21. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats
22. Effects of salicylate on pharmacokinetics of valproic acid in rats